2-(Cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide

Catalog No. :
ACXQXZ535
CAS No. :
1804942-72-0
Molecular Formula :
C25H23FN2O4
Molecular Weight :
434.47

IUPAC Name:2-(cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide

2-(Cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$262.00Login to see priceInquiryInquiry
250mg98%$433.00Login to see priceInquiryInquiry
1g98%$862.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide
IUPAC Name2-(cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide
Molecular FormulaC25H23FN2O4
Molecular Weight434.47
SMILESO=C(NCC1=CC=C(OC)C(F)=C1)C2=CC(C3=NC=CC=C3C=O)=CC=C2OCC4CC4
InChI KeyQGQPYJCYNNIJCQ-UHFFFAOYSA-N
SynonymBenzamide, 2-?(cyclopropylmethoxy)?-?N-?[(3-?fluoro-?4-?methoxyphenyl)?methyl]?-?5-?(3-?formyl-?2-?pyridinyl)?-;2-(Cyclopropylmethoxy)-N-(3-fluoro-4-methoxybenzyl)-5-(3-formylpyridin-2-yl)benzamide
CAS No.1804942-72-0

Synthetic Route by SureRoute

1. ACXQXZ535 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPAFO014 route compound structure diagram
    ACPAFO014128071-75-0 In Stock
  4. Then
  5. ACXQXZ535 route product structure diagram
    ACXQXZ5351804942-72-0
Inquiry

2. ACXQXZ535 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPDQ918 route compound structure diagram
    ACCPDQ918123652-95-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXQXZ535 route product structure diagram
    ACXQXZ5351804942-72-0
Inquiry

Comments (0)